Skip to main content

Glycopyrrolate

NDC 62332-607 · Alembic Pharmaceuticals Inc.

Generic nameGlycopyrrolate
Dosage formINJECTION
RouteINTRAMUSCULAR, INTRAVENOUS
Active ingredient(s)GLYCOPYRROLATE
Strength.2 mg/mL
Pharmacologic classAnticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
Marketing categoryANDA

Packages

62332-607-25 — 25 VIAL in 1 CARTON (62332-607-25) / 1 mL in 1 VIAL (62332-607-01)

Billed under HCPCS

J1596 — Injection, glycopyrrolate, 0.1 mg Medicare Part B payment limit (ASP + 6%): $0.33

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55150-293 — Glycopyrrolate, 55150-294 — Glycopyrrolate, 55150-295 — Glycopyrrolate, 55154-7475 — Glycopyrrolate, 59651-435 — GLYCOPYRROLATE, 60429-666 — GLYCOPYRROLATE, 60687-458 — GLYCOPYRROLATE, 62135-734 — Glycopyrrolate, 62135-735 — Glycopyrrolate, 62135-961 — Glycopyrrolate, 62332-627 — Glycopyrrolate, 62332-628 — Glycopyrrolate, 62332-629 — Glycopyrrolate, 63323-578 — Glycopyrrolate, 63629-2206 — glycopyrrolate, 63629-2207 — glycopyrrolate, 63629-7207 — GLYCOPYRROLATE, 63629-9287 — glycopyrrolate, 63629-9592 — Glycopyrrolate, 65145-102 — Glycopyrrolate, +177 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources